Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo.
about
Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responsesPre-treatment deep curettage can significantly reduce tumour thickness in thick Basal cell carcinoma while maintaining a favourable cosmetic outcome when used in combination with topical photodynamic therapyEmpirical Modeling of Physiochemical Immune Response of Multilayer Zinc Oxide Nanomaterials under UV Exposure to Melanoma and Foreskin FibroblastsWhite light-informed optical properties improve ultrasound-guided fluorescence tomography of photoactive protoporphyrin IX.The Role of Photodynamic Therapy in the Treatment of Vulvar Intraepithelial Neoplasia.
P2860
Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Bioavailability of aminolaevul ...... y using microdialysis in vivo.
@en
Bioavailability of aminolaevul ...... y using microdialysis in vivo.
@nl
type
label
Bioavailability of aminolaevul ...... y using microdialysis in vivo.
@en
Bioavailability of aminolaevul ...... y using microdialysis in vivo.
@nl
prefLabel
Bioavailability of aminolaevul ...... y using microdialysis in vivo.
@en
Bioavailability of aminolaevul ...... y using microdialysis in vivo.
@nl
P2093
P1476
Bioavailability of aminolaevul ...... dy using microdialysis in vivo
@en
P2093
A-L Krogstad
A-M Wennberg
C B Halldin
C Sandberg
P304
P356
10.1111/J.1365-2133.2008.08795.X
P407
P577
2008-08-19T00:00:00Z